Citations

Mayo Clinic

Clear

4085 citation(s) found for "Uy, Jonathan J".

Prevalence and clinical correlates of vulnerable status using the Vulnerable Elders Survey 13 (VES-13) in newly diagnosed adult non-Hodgkin lymphoma (NHL) patients: A LEO cross-sectional analysis.
Martin, Peter , Thompson, Carrie A. , Lossos, Izidore S. , Allmer, Cristine, Feldman, Andew L., Friedberg, Jonathan W. , Flowers, Christopher R. , Famà, Angelo , Casulo, Carla , Nastoupil, Loretta J. , Link, Brian K. , Kahl, Brad S. , Maurer, Matthew J. , Jaye, David L. , Slager, Susan L. , Habermann, Thomas M. , Cerhan, James R.

Journal of Clinical Oncology | September 5, 2018 | Volume: 36 | Issue: 15_suppl | Pages: 10042-10042

10.1200/jco.2018.36.15_suppl.10042 Get It

Outcomes with chemotherapy for metastatic non-small cell lung cancer (mNSCLC) in patients previously treated with immune checkpoint inhibitors (CPI).
Elnair, Radowan , Chang, Guy vin, Powell, Steven , Sumey, Christopher , Bleeker, Jonathan

Journal of Clinical Oncology | September 5, 2018 | Volume: 36 | Issue: 15_suppl | Pages: e21119-e21119

10.1200/jco.2018.36.15_suppl.e21119 Get It

Interim analysis of a prospective, randomized, double blind, placebo controlled, phase IIb trial of the TLPLDC vaccine to prevent recurrence in resected stage III or IV melanoma patients.
Myers, John W., Hale, Diane F. , Brown, Tommy A., Vreeland, Timothy J. , Andtbacka, Robert Hans Ingemar, Berger, Adam C. , Terando, Alicia M. , Faries, Mark B. , Peoples, George E. , Clifton, Guy T. , Jakub, James W. , Sussman, Jonathan

Journal of Clinical Oncology | September 5, 2018 | Volume: 36 | Issue: 15_suppl | Pages: 9525-9525

10.1200/jco.2018.36.15_suppl.9525 Get It

QUADRA: A phase 2, open-label, single-arm study to evaluate niraparib in patients (pts) with relapsed ovarian cancer (ROC) who have received ≥3 prior chemotherapy regimens.
Miller, David S. , Cloven, Noelle, Hendrickson, Andrea E. Wahner , DiSilvestro, Paul , Cristea, Mihaela , Berek, Jonathan S. , Chan, John K. , Clark, Romnee, Matulonis, Ursula A. , Monk, Bradley J. , Miller, David S , Moore, Kathleen N. , Secord, Angeles Alvarez , Geller, Melissa Ann , Fleming, Gini F. , Azodi, Masoud , Oza, Amit M. , Li, Yong

Journal of Clinical Oncology | September 5, 2018 | Volume: 36 | Issue: 15_suppl | Pages: 5514-5514

10.1200/jco.2018.36.15_suppl.5514 Get It

Distinct impacts of KRAS, NRAS and BRAF mutations on survival of patients with metastatic colorectal cancer.
Yu, Cecilia, Tschautscher, Marcella , Briggler, Andrew M., Overman, Michael J. , Broaddus, Russell R. , Balcom, Jessica R. , Kipp, Benjamin R. , Grothey, Axel, Wang, Yucai , Loree, Jonathan M. , Meric‐Bernstam, Funda , Jones, Jeremy C , Kopetz, Scott

Journal of Clinical Oncology | September 5, 2018 | Volume: 36 | Issue: 15_suppl | Pages: 3513-3513

10.1200/jco.2018.36.15_suppl.3513 Get It

ILyAD (Indolent Lymphoma and Vitamin D): A phase III double blind, prospective randomized trial to evaluate the supplemental effect of vitamin D on progression-free survival in patients with low tumor-burden indolent non-Hodgkin lymphoma treated with ritux
Strawderman, Myla , Flowers, Christopher R. , Leonard, John P. , Peterson, Derick R., Friedberg, Jonathan W. , Brady, Michael, Kahl, Brad S. , Nastoupil, Loretta J. , Witzig, Thomas E.

Journal of Clinical Oncology | September 5, 2018 | Volume: 36 | Issue: 15_suppl | Pages: TPS7587-TPS7587

10.1200/jco.2018.36.15_suppl.tps7587 Get It

Brentuximab vedotin (BV) plus chemotherapy in patients with newly diagnosed advanced stage Hodgkin lymphoma (HL): North American results.
Ramchandren, Radhakrishnan , Advani, Ranjana H. , Ansell, Stephen M. , Bartlett, Nancy L. , Chen, Robert W., Feldman, Tatyana , Forero‐Torres, Andres , Friedberg, Jonathan W. , Straus, David J. , Younes, Anas , Fenton, Keenan , Manley, Thomas, Engley, Gerald, Bartlett, Nancy L , Advani, Ranjana H , Gopal, Ajay K. , Gordon, Leo I. , Kuruvilla, John , Savage, Kerry J. , Connors, Joseph M.

Journal of Clinical Oncology | September 5, 2018 | Volume: 36 | Issue: 15_suppl | Pages: 7541-7541

10.1200/jco.2018.36.15_suppl.7541 Get It

Clinical outcomes in patients with baseline renal dysfunction in the NETTER-1 study: 177Lu-Dotatate vs. high dose octreotide in progressive midgut neuroendocrine tumors.
Wolin, Edward M. , Chasen, Beth, Kulke, Matthew H. , Caplin, Martyn , Baum, Richard P. , Hobday, Timothy J. , Hendifar, Andrew , Ravasi, Laura, Öberg, Kjell E., Ruszniewski, Philippe, Krenning, Eric P. , Strosberg, Jonathan , Bushnell, David

Journal of Clinical Oncology | September 5, 2018 | Volume: 36 | Issue: 15_suppl | Pages: 4102-4102

10.1200/jco.2018.36.15_suppl.4102 Get It

First update on overall survival, progression-free survival, and health-related time-to-deterioration quality of life from the NETTER-1 study: 177Lu-Dotatate vs. high dose octreotide in progressive midgut neuroendocrine tumors.
Wolin, Edward M. , Chasen, Beth, Kulke, Matthew H. , Caplin, Martyn , Baum, Richard P. , Hobday, Timothy J. , Hendifar, Andrew , Sierra, Maribel Lopera , Öberg, Kjell E., Ruszniewski, Philippe, Krenning, Eric P. , Strosberg, Jonathan , Bushnell, David

Journal of Clinical Oncology | September 5, 2018 | Volume: 36 | Issue: 15_suppl | Pages: 4099-4099

10.1200/jco.2018.36.15_suppl.4099 Get It

Recurrent desmoid-type fibromatosis associated with underlying neuromuscular choristoma
Stone, Jonathan J. , Prasad, Nikhil K. , Howe, B. Matthew, Amrami, Kimberly K. , Carter, Jodi M. , Jentoft, Mark E. , Spinner, Robert J. , Laumonerie, Pierre , Carter, Jodi

Journal of Neurosurgery | August 31, 2018 | Volume: 131 | Issue: 1 | Pages: 175-183

10.3171/2018.3.jns152935 | PMID 30168738 Get It

OBJECTIVEDesmoid-type fibromatosis (DTF) presents a therapeutic dilemma. While lacking metastatic potential, it is a locally aggressive tumor with a strong propensity for occurrence near nerve(s) and recurrence following resection. In this study, the authors introduce the association of an occult neuromuscular choristoma (NMC) identified in patients with DTF.METHODSAfter experiencing a case of DTF found to have an occult NMC, the authors performed a retrospective database review of all other cases of biopsy-proven DTF involving the extremities or limb girdles in patients with available MRI data. Two musculoskeletal radiologists with expertise in peripheral nerve imaging reviewed the MRI studies of the eligible cases for evidence of previously unrecognized NMC.RESULTSThe initial case of a patient with an occult sciatic NMC is described. The database review yielded 40 patients with DTF—18 (45%) in the upper limb and 22 (55%) in the lower limb. Two cases (5%) had MRI findings of NMC associated with the DTF, one in the proximal sciatic nerve and the other in the proximal tibial and sural nerves.CONCLUSIONSThe coexistence of NMC may be under-recognized in a subset of patients with extremity DTF. This finding poses implications for DTF treatment and the likelihood of recurrence after resection or biopsy. Further study may reveal crucial links between the pathogenesis of NMC and DTF and offer novel therapeutic strategies.